Managing the Use and Dissemination of Information about Biomarkers: The Importance of Incentive Structures

Journal of Law, Medicine and Ethics 47 (3):396-397 (2019)
  Copy   BIBTEX

Abstract

The use of biomarkers holds great promise for the development of new therapeutics and the acceleration of clinical research. However, biomarkers must be validated — a complex and costly endeavor. Importantly, biomarker validation is meaningfully shaped by economic and policy-driven incentives.

Categories

Keywords

Reprint years

DOI

10.1177/1073110519876171

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,853

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

On the personal utility of Alzheimer’s disease-related biomarker testing in the research context.Eline M. Bunnik, Edo Richard, Richard Milne & Maartje H. N. Schermer - 2018 - Journal of Medical Ethics 44 (12):830-834.
Information Channels and Biomarkers of Disease.Phyllis Illari & Federica Russo - 2016 - Topoi 35 (1):175-190.
Biomarkers in the Ontology for General Medical Science.Werner Ceusters & Barry Smith - 2015 - In Ronald Cornet (ed.), Digital Healthcare Empowering Europeans. IOS Press. pp. 155-159.
How Clinical Trial Data Sharing Platforms Can Advance the Study of Biomarkers.Rebecca Li & Ida Sim - 2019 - Journal of Law, Medicine and Ethics 47 (3):369-373.
Some ethical considerations about the use of biomarkers for the classification of adult antisocial individuals.Marko Jurjako, Luca Malatesti & Inti A. Brazil - 2019 - International Journal of Forensic Mental Health 18 (3):228-242.
Biomarkers as Surrogate Endpoints: Ongoing Opportunities for Validation.Audrey D. Zhang & Joseph S. Ross - 2019 - Journal of Law, Medicine and Ethics 47 (3):393-395.
Pre-emptive suicide, precedent autonomy and preclinical Alzheimer disease.Rebecca Dresser - 2014 - Journal of Medical Ethics 40 (8):550-551.
A guide to stem cell identification: Progress and challenges in system‐wide predictive testing with complex biomarkers.Roy Williams, Bernhard Schuldt & Franz-Josef Müller - 2011 - Bioessays 33 (11):880-890.
Oncogenic microRNAs (OncomiRs) as a new class of cancer biomarkers.Vladimir A. Krutovskikh & Zdenko Herceg - 2010 - Bioessays 32 (10):894-904.
Biomarkers of environmental tobacco smoke exposure.N. L. Benowitz - unknown
Biomarkers of secondhand smoke exposure in automobiles.I. A. Jones, G. St Helen, M. J. Meyers, C. da DempseyHavel, P. Jacob, A. Northcross, S. K. Hammond & N. L. Benowitz - unknown
The Importance of the Validation of M/EEG With Current Biomarkers in Alzheimer's Disease.Fernando Maestú, Pablo Cuesta, Omar Hasan, Alberto Fernandéz, Michael Funke & Paul E. Schulz - 2019 - Frontiers in Human Neuroscience 13.
Corrigendum: The Importance of the Validation of M/EEG With Current Biomarkers in Alzheimer's Disease.Fernando Maestú, Pablo Cuesta, Omar Hasan, Alberto Fernandéz, Michael Funke & Paul E. Schulz - 2019 - Frontiers in Human Neuroscience 13.
Challenges and Opportunities for Biomarker Validation.Spencer Phillips Hey, Elvira D'Andrea, Emily H. Jung, Frazer Tessema, Jing Luo, Bishal Gyawali & Aaron S. Kesselheim - 2019 - Journal of Law, Medicine and Ethics 47 (3):357-361.
Resenha do livro Neuroethics of Biomarkers. [REVIEW]Darlei Dall'Agnol, Mônica Franco & Silvio Kavetski - 2018 - Ethic@ - An International Journal for Moral Philosophy 17 (1):147-157.

Analytics

Added to PP
2019-09-28

Downloads
5 (#1,540,244)

6 months
1 (#1,471,470)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

How Clinical Trial Data Sharing Platforms Can Advance the Study of Biomarkers.Rebecca Li & Ida Sim - 2019 - Journal of Law, Medicine and Ethics 47 (3):369-373.

Add more references